People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Pharmaceuticals, Investment Vehicle
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Manhattan Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $59.5M | $850.1M | 2011 |
| Power Fund Holdings, LLC | — | Investment Vehicle | Pre-Seed | $600K | $4.9M | 2022 |
SEAN POWER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SEAN POWER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Weiss | 1 | 8 |
| Timothy McInerney | 1 | 4 |
| NEIL HERSKOWITZ | 1 | 3 |
| Richard Steinhart | 1 | 1 |
| CALEB DEROSIERS | 1 | 1 |
| WILLIAM P. FORRY | 1 | 1 |
| MICHAEL P. MCNEIL | 1 | 1 |
| Douglas Abel | 1 | 1 |
| Michael McGuinness | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.